{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T01:13:01Z","timestamp":1790817181303,"version":"4.1.0"},"reference-count":64,"publisher":"Elsevier BV","issue":"31-32","license":[{"start":{"date-parts":[[2004,10,1]],"date-time":"2004-10-01T00:00:00Z","timestamp":1096588800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2004,10]]},"DOI":"10.1016\/j.vaccine.2004.04.033","type":"journal-article","created":{"date-parts":[[2004,6,9]],"date-time":"2004-06-09T20:23:03Z","timestamp":1086812583000},"page":"4270-4281","source":"Crossref","is-referenced-by-count":25,"title":["Adjuvanticity of native and detoxified adenylate cyclase toxin of Bordetella pertussis towards co-administered antigens"],"prefix":"10.1016","volume":"22","author":[{"given":"Julia","family":"MacDonald-Fyall","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dorothy","family":"Xing","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Corbel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susan","family":"Baillie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roger","family":"Parton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Coote","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2004.04.033_bib1","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/S0031-3955(05)70209-1","article-title":"Acellular pertussis vaccines","volume":"47","author":"Decker","year":"2000","journal-title":"Pediatr. Clin. N. Am."},{"key":"10.1016\/j.vaccine.2004.04.033_bib2","doi-asserted-by":"crossref","first-page":"175","DOI":"10.2165\/00063030-199912030-00002","article-title":"Developing better pediatric vaccines","volume":"12","author":"Halperin","year":"1999","journal-title":"BioDrugs"},{"key":"10.1016\/j.vaccine.2004.04.033_bib3","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1097\/00006454-199705000-00011","article-title":"The acellular pertussis vaccine trials: an interpretation","volume":"16","author":"Plotkin","year":"1997","journal-title":"Pediatr. Infect. Dis. J."},{"key":"10.1016\/j.vaccine.2004.04.033_bib4","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/0882-4010(88)90061-7","article-title":"Cloning of the adenylate cyclase genetic determinant of Bordetella pertussis and its expression in Escherichia coli and Bordetella pertussis","volume":"4","author":"Brownlie","year":"1988","journal-title":"Microb. Pathog."},{"key":"10.1016\/j.vaccine.2004.04.033_bib5","doi-asserted-by":"crossref","first-page":"3445","DOI":"10.1128\/IAI.58.10.3445-3447.1990","article-title":"Adenylate cyclase toxin is critical for lethal infection by Bordetella pertussis in infant mice","volume":"58","author":"Goodwin","year":"1990","journal-title":"Infect. Immun."},{"key":"10.1016\/j.vaccine.2004.04.033_bib6","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/0882-4010(92)90057-U","article-title":"Both adenylate cyclase and hemolytic activities are required for Bordetella pertussis to initiate infection","volume":"12","author":"Khelef","year":"1992","journal-title":"Microb. Pathog."},{"key":"10.1016\/j.vaccine.2004.04.033_bib7","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1093\/infdis\/150.2.219","article-title":"Pertussis toxin and extracytoplasmic adenylate cyclase as virulence factors of Bordetella pertussis","volume":"150","author":"Weiss","year":"1984","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.vaccine.2004.04.033_bib8","doi-asserted-by":"crossref","first-page":"1718","DOI":"10.1128\/IAI.66.4.1718-1725.1998","article-title":"Role of adenylate cyclase-hemolysin in alveolar macrophage apoptosis during Bordetella pertussis infection in vivo","volume":"66","author":"Gueirard","year":"1998","journal-title":"Infect. Immun."},{"key":"10.1016\/j.vaccine.2004.04.033_bib9","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1016\/0968-0004(89)90106-0","article-title":"Invasive adenylate cyclase toxin of B. pertussis","volume":"14","author":"Hanski","year":"1989","journal-title":"Trends Biochem. Sci."},{"key":"10.1016\/j.vaccine.2004.04.033_bib10","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/S0966-842X(99)01468-7","article-title":"Bordetella pertussis adenylate cyclase: a toxin with multiple talents","volume":"4","author":"Ladant","year":"1999","journal-title":"Trends Microbiol."},{"key":"10.1016\/j.vaccine.2004.04.033_bib11","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1093\/infdis\/163.1.135","article-title":"Human serological responses to envelope associated proteins and adenylate cyclase toxin of Bordetella pertussis","volume":"163","author":"Arciniega","year":"1991","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.vaccine.2004.04.033_bib12","doi-asserted-by":"crossref","first-page":"3583","DOI":"10.1128\/IAI.61.9.3583-3589.1993","article-title":"CyaC mediated activation is important not only for toxic but also for protective activities of Bordetella pertussis adenylate cyclase-hemolysin","volume":"61","author":"Betsou","year":"1993","journal-title":"Infect. Immun."},{"key":"10.1016\/j.vaccine.2004.04.033_bib13","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1099\/00222615-32-3-173","article-title":"Antibodies to Bordetella pertussis adenylate cyclase are produced in man during pertussis infection and after vaccination","volume":"32","author":"Farfel","year":"1990","journal-title":"J. Med. Microbiol."},{"key":"10.1016\/j.vaccine.2004.04.033_bib14","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/0882-4010(89)90040-5","article-title":"Bordetella adenylate cyclase is a virulence associated factor and an immunoprotective antigen","volume":"7","author":"Guiso","year":"1989","journal-title":"Microb. Pathog."},{"key":"10.1016\/j.vaccine.2004.04.033_bib15","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1016\/0882-4010(91)90038-C","article-title":"Protective activity of Bordetella adenylate cyclase-hemolysin against bacterial colonisation","volume":"11","author":"Guiso","year":"1991","journal-title":"Microb. Pathog."},{"key":"10.1016\/j.vaccine.2004.04.033_bib16","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1111\/j.1574-695X.1999.tb01248.x","article-title":"Adjuvant and protective properties of native and recombinant Bordetella pertussis adenylate cyclase toxin preparations in mice","volume":"23","author":"Hormozi","year":"1999","journal-title":"FEMS Immunol. Med. Microbiol."},{"key":"10.1016\/j.vaccine.2004.04.033_bib17","doi-asserted-by":"crossref","first-page":"3309","DOI":"10.1128\/IAI.63.9.3309-3315.1995","article-title":"The C-terminal domain is essential for protective activity of the Bordetella pertussis adenylate cyclase-hemolysin","volume":"63","author":"Betsou","year":"1995","journal-title":"Infect. Immun."},{"key":"10.1016\/j.vaccine.2004.04.033_bib18","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/S0378-1119(96)00412-X","article-title":"Bordetella pertussis adenylate cyclase toxin: proCyaA and CyaC proteins synthesised separately in Escherichia coli produce active toxin in vitro","volume":"180","author":"Westrop","year":"1996","journal-title":"Gene"},{"key":"10.1016\/j.vaccine.2004.04.033_bib19","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1128\/jb.179.3.871-879.1997","article-title":"Structure-function studies of the adenylate cyclase toxin of Bordetella pertussis and the leukotoxin of Pasteurella haemolytica by heterologous C protein activation and construction of hybrid toxins","volume":"179","author":"Westrop","year":"1997","journal-title":"J. Bacteriol."},{"key":"10.1016\/j.vaccine.2004.04.033_bib20","doi-asserted-by":"crossref","first-page":"2244","DOI":"10.1016\/S0021-9258(18)45869-3","article-title":"Insertional mutagenesis of Bordetella pertussis adenylate cyclase","volume":"267","author":"Ladant","year":"1992","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.vaccine.2004.04.033_bib21","doi-asserted-by":"crossref","first-page":"13598","DOI":"10.1016\/S0021-9258(18)42254-5","article-title":"Bordetella pertussis adenylate cyclase toxin: structural and functional independence of the catalytic and hemolytic activities","volume":"267","author":"Sakamoto","year":"1992","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.vaccine.2004.04.033_bib22","doi-asserted-by":"crossref","first-page":"4015","DOI":"10.1016\/S0021-9258(19)84954-2","article-title":"Characterisation of the calmodulin-binding and of the catalytic domains of Bordetella pertussis adenylate cyclase","volume":"264","author":"Ladant","year":"1989","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.vaccine.2004.04.033_bib23","doi-asserted-by":"crossref","first-page":"22289","DOI":"10.1074\/jbc.M106701200","article-title":"A direct pyrophosphate-coupled assay provides new insights into the activation of the secreted adenylate cyclase from Bordetella pertussis by calmodulin","volume":"277","author":"Lawrence","year":"2002","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.vaccine.2004.04.033_bib24","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/0003-2697(76)90527-3","article-title":"A rapid and sensitive method for the quantitation of microgram quantities of protein using the principle of protein-dye binding","volume":"72","author":"Bradford","year":"1976","journal-title":"Anal. Biochem."},{"key":"10.1016\/j.vaccine.2004.04.033_bib25","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1016\/S0264-410X(98)00235-7","article-title":"An aerosol challenge model of Bordetella pertussis infcetion as a potential bioassay for acellular pertussis vaccines","volume":"17","author":"Xing","year":"1999","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2004.04.033_bib26","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1006\/biol.2001.0288","article-title":"International collaborative study: evaluation of proposed International Reference Reagent of pertussis antiserum (mouse) 97\/642","volume":"29","author":"Gaines Das","year":"2001","journal-title":"Biologicals"},{"key":"10.1016\/j.vaccine.2004.04.033_bib27","doi-asserted-by":"crossref","first-page":"888","DOI":"10.4049\/jimmunol.150.3.888","article-title":"Release of nitric oxide during the T-cell independent pathway of macrophage activation","volume":"150","author":"Beckerman","year":"1993","journal-title":"J. Immunol."},{"key":"10.1016\/j.vaccine.2004.04.033_bib28","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/S0264-410X(97)00157-6","article-title":"Nitric oxide induction in murine macrophages and spleen cells by whole-cell Bordetella pertussis vaccine","volume":"16","author":"Xing","year":"1998","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2004.04.033_bib29","first-page":"95","article-title":"In vitro and in vivo induction of nitric oxide by murine macrophages stimulated with Bordetella pertussis","volume":"13","author":"Torre","year":"1996","journal-title":"FEMS Immunol. Med. Microbiol."},{"key":"10.1016\/j.vaccine.2004.04.033_bib30","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1111\/j.1574-6968.1995.tb07909.x","article-title":"Induction of macrophage apoptosis by Bordetella pertussis adenylate cyclase-hemolysin","volume":"134","author":"Khelef","year":"1995","journal-title":"FEMS Microbiol. Letts."},{"key":"10.1016\/j.vaccine.2004.04.033_bib31","doi-asserted-by":"crossref","first-page":"8332","DOI":"10.1016\/S0021-9258(18)53100-8","article-title":"Antiapoptotic effect of heterozygously expressed mutant R1 (Ala366-Asp) subunit of cAMP kinase 1 in a rat leukaemia cell line","volume":"268","author":"Duprez","year":"1993","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.vaccine.2004.04.033_bib32","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1128\/IAI.68.2.956-959.2000","article-title":"Phagocytosed Bordetella pertussis fails to survive in human neutrophils","volume":"68","author":"Lenz","year":"2000","journal-title":"Infect. Immun."},{"key":"10.1016\/j.vaccine.2004.04.033_bib33","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1128\/IAI.68.3.1383-1390.2000","article-title":"A regulatory role for interleukin 4 in differential inflammatory responses in the lung following infection of mice primed with Th1- or Th2-inducing pertussis vaccines","volume":"68","author":"McGuirk","year":"2000","journal-title":"Infect. Immun."},{"key":"10.1016\/j.vaccine.2004.04.033_bib34","doi-asserted-by":"crossref","first-page":"7152","DOI":"10.1128\/IAI.68.12.7152-7155.2000","article-title":"Neutralising antibodies to adenylate cyclase toxin promote phagocytosis of Bordetella pertussis by human neutrophils","volume":"68","author":"Weingart","year":"2000","journal-title":"Infect. Immun."},{"key":"10.1016\/j.vaccine.2004.04.033_bib35","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1093\/intimm\/6.9.1333","article-title":"cAMP upregulates IL-4 and IL-5 production from activated CD4+ T cells while decreasing IL-2 release and NF-AT induction","volume":"6","author":"Lacour","year":"1994","journal-title":"J. Int. Immun."},{"key":"10.1016\/j.vaccine.2004.04.033_bib36","series-title":"Pathogenesis and Immunity in Pertussis","first-page":"173","article-title":"Action of pertussigen (pertussis toxin) on the host immune system","author":"Munoz","year":"1988"},{"key":"10.1016\/j.vaccine.2004.04.033_bib37","doi-asserted-by":"crossref","first-page":"2100","DOI":"10.1128\/IAI.63.6.2100-2108.1995","article-title":"A mutant pertussis toxin molecule that lacks ADP-ribosyltransferase activity, PT-9K\/129G, is an effective mucosal adjuvant for intranasally delivered proteins","volume":"63","author":"Roberts","year":"1995","journal-title":"Infect. Immun."},{"key":"10.1016\/j.vaccine.2004.04.033_bib38","doi-asserted-by":"crossref","first-page":"1841","DOI":"10.1084\/jem.191.11.1841","article-title":"Protective immunity to Bordetella pertussis requires both B cells and CD4+ T cells for key functions other than specific antibody production","volume":"191","author":"Leef","year":"2000","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.vaccine.2004.04.033_bib39","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1128\/IAI.61.2.399-410.1993","article-title":"Cell-mediated immunity to Bordetella pertussis: role of Th1 cells in bacterial clearance in a murine respiratory infection model","volume":"61","author":"Mills","year":"1993","journal-title":"Infect. Immun."},{"key":"10.1016\/j.vaccine.2004.04.033_bib40","doi-asserted-by":"crossref","first-page":"1246","DOI":"10.1086\/593682","article-title":"Bordetella pertussis respiratory infection in children is associated with preferential activation of type 1 T helper cells","volume":"175","author":"Ryan","year":"1997","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.vaccine.2004.04.033_bib41","doi-asserted-by":"crossref","first-page":"2110","DOI":"10.1016\/S0264-410X(99)00562-9","article-title":"Effect of pertussis toxin on the induction of nitric oxide synthesis in murine macrophages and on protection in vivo","volume":"18","author":"Xing","year":"2000","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2004.04.033_bib42","doi-asserted-by":"crossref","first-page":"2407","DOI":"10.4049\/jimmunol.141.7.2407","article-title":"Release of reactive nitrogen intermediates and reactive oxygen intermediates from mouse peritoneal macrophages. Comparison of activating cytokines and evidence for independent production","volume":"141","author":"Ding","year":"1988","journal-title":"J. Immunol."},{"key":"10.1016\/j.vaccine.2004.04.033_bib43","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.4049\/jimmunol.150.3.1011","article-title":"Pertussis toxin-sensitive factor differentially regulates lipopolysaccharide-induced tumor necrosis factor-\u03b1 and nitric oxide production in mouse peritoneal macrphages","volume":"150","author":"Zhang","year":"1993","journal-title":"J. Immunol."},{"key":"10.1016\/j.vaccine.2004.04.033_bib44","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1128\/IAI.64.4.1309-1313.1996","article-title":"Nitric oxide induction by pertussis toxin in mouse spleen cells via gamma interferon","volume":"64","author":"Sakurai","year":"1996","journal-title":"Infect. Immun."},{"key":"10.1016\/j.vaccine.2004.04.033_bib45","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/S0167-5699(99)01523-6","article-title":"Structure and mucosal adjuvanticity of cholera and Escherichia coli heat-labile enterotoxins","volume":"20","author":"Rappuoli","year":"1999","journal-title":"Immunol. Today"},{"key":"10.1016\/j.vaccine.2004.04.033_bib46","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1093\/intimm\/10.5.651","article-title":"Pertussis toxin potentiates Th1 and Th2 responses to co-injected antigen: adjuvant action is associated with enhanced regulatory cytokine production and expression of the co-stimulatory molecules B7-1, B7-2 and CD28","volume":"10","author":"Ryan","year":"1998","journal-title":"Int. Immunol."},{"key":"10.1016\/j.vaccine.2004.04.033_bib47","doi-asserted-by":"crossref","first-page":"6270","DOI":"10.1128\/IAI.67.12.6270-6280.1999","article-title":"Mutants of Escherichia coli heat-labile toxin act as effective mucosal adjuvants for nasal delivery of an acellular pertussis vaccine: differential effects of the nontoxic AB complex and enzyme activity on Th1 and Th2 cells","volume":"67","author":"Ryan","year":"1999","journal-title":"Infect. Immun."},{"key":"10.1016\/j.vaccine.2004.04.033_bib48","doi-asserted-by":"crossref","first-page":"5750","DOI":"10.4049\/jimmunol.165.10.5750","article-title":"Modulation of innate and acquired immune responses by Escherichia coli heat-labile toxin: distinct pro- and anti-inflammatory effects of the nontoxic AB complex and the enzyme activity","volume":"165","author":"Ryan","year":"2000","journal-title":"J. Immunol."},{"key":"10.1016\/j.vaccine.2004.04.033_bib49","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1189\/jlb.72.5.962","article-title":"Pertussis toxin and adenylate cyclase toxin from Bordetella pertussis activate human monocyte-derived dendritic cells and dominantly inhibit cytokine production through a cAMP-dependent pathway","volume":"72","author":"Bagley","year":"2002","journal-title":"J. Leuk. Biol."},{"key":"10.1016\/j.vaccine.2004.04.033_bib50","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1086\/341510","article-title":"Native and genetically inactivated pertussis toxins induce human dendritic cell maturation and synergize with lipopolysaccharide in promoting T helper type 1 responses","volume":"186","author":"Ausiello","year":"2002","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.vaccine.2004.04.033_bib51","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.1084\/jem.191.9.1605","article-title":"Primary role for Gi protein signalling in the regulation of interleukin 12 production and the induction of T helper cell type 1 responses","volume":"191","author":"He","year":"2000","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.vaccine.2004.04.033_bib52","doi-asserted-by":"crossref","first-page":"1728","DOI":"10.4049\/jimmunol.170.4.1728","article-title":"Pertussis toxin enhances Th 1 responses by stimulation of dendritic cells","volume":"170","author":"Hou","year":"2003","journal-title":"J. Immunol."},{"key":"10.1016\/j.vaccine.2004.04.033_bib53","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1084\/jem.193.9.1035","article-title":"The adenylate cyclase toxin of Bordetella pertussis binds to target cells via the alpha(M)beta(2) integrin (CD11b\/CD18)","volume":"193","author":"Guermonprez","year":"2001","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.vaccine.2004.04.033_bib54","doi-asserted-by":"crossref","first-page":"6552","DOI":"10.4049\/jimmunol.162.11.6552","article-title":"Analysis of adjuvant function by direct visualisation of antigen presentation in vivo: endotoxin promotes accumulation of antigen-bearing dendritic cells in the T cell areas of lymphoid tissue","volume":"162","author":"Reis e Sousa","year":"1999","journal-title":"J. Immunol."},{"key":"10.1016\/j.vaccine.2004.04.033_bib55","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1016\/S1286-4579(01)01421-6","article-title":"Immunity to Bordetella pertussis","volume":"3","author":"Mills","year":"2001","journal-title":"Microb. Infect."},{"key":"10.1016\/j.vaccine.2004.04.033_bib56","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1016\/S0264-410X(00)00253-X","article-title":"Investigation of cellular and humoral immune responses to whole cell and acellular pertussis vaccines","volume":"19","author":"Canthaboo","year":"2001","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2004.04.033_bib57","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1046\/j.1365-2567.1996.497560.x","article-title":"Th1\/Th2 dichotomy in acquired immunity to B. pertussis: variables in the in vivo priming and in vitro cytokine detection techniques affect the classification of T cell subsets as Th1, Th2 or Th0","volume":"87","author":"Barnard","year":"1996","journal-title":"Immunology"},{"key":"10.1016\/j.vaccine.2004.04.033_bib58","doi-asserted-by":"crossref","first-page":"5295","DOI":"10.1128\/IAI.64.12.5295-5301.1996","article-title":"IL-12 is produced by macrophages in response to live or killed Bordetella pertussis and enhances the efficacy of an acellular pertussis vaccine by promoting induction of Th1 cells","volume":"64","author":"Mahon","year":"1996","journal-title":"Infect. Immun."},{"key":"10.1016\/j.vaccine.2004.04.033_bib59","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1128\/IAI.66.2.594-602.1998","article-title":"A murine model in which protection correlates with pertussis vaccine efficacy in children reveals complementary roles for humoral and cell-mediated immunity in protection against Bordetella pertussis","volume":"66","author":"Mills","year":"1998","journal-title":"Infect. Immun."},{"key":"10.1016\/j.vaccine.2004.04.033_bib60","doi-asserted-by":"crossref","first-page":"4563","DOI":"10.1128\/IAI.60.11.4563-4570.1992","article-title":"Proliferative responses and gamma interferon and tumor necrosis factor production by lymphocytes isolated from tracheobronchial lymph nodes and spleens of mice aerosol infected with Bordetella pertussis","volume":"60","author":"Petersen","year":"1992","journal-title":"Infect. Immun."},{"key":"10.1016\/j.vaccine.2004.04.033_bib61","doi-asserted-by":"crossref","first-page":"3190","DOI":"10.1128\/IAI.61.8.3190-3198.1993","article-title":"Effective immunization against Bordetella pertussis respiratory infection in mice is dependent on induction of cell-mediated immunity","volume":"61","author":"Redhead","year":"1993","journal-title":"Infect. Immun."},{"key":"10.1016\/j.vaccine.2004.04.033_bib62","doi-asserted-by":"crossref","first-page":"3768","DOI":"10.1128\/IAI.59.10.3768-3773.1991","article-title":"Lymphokine secretion and cytotoxic activity of human CD4+ T cell clones against Bordetella pertussis","volume":"59","author":"Peppoloni","year":"1991","journal-title":"Infect. Immun."},{"key":"10.1016\/j.vaccine.2004.04.033_bib63","doi-asserted-by":"crossref","first-page":"2168","DOI":"10.1128\/IAI.65.6.2168-2174.1997","article-title":"Vaccine- and antigen-dependent type 1 and type 2 cytokine induction after primary vaccination of infants with whole cell or acellular pertussis vaccines","volume":"65","author":"Ausiello","year":"1997","journal-title":"Infect. Immun."},{"key":"10.1016\/j.vaccine.2004.04.033_bib64","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1046\/j.1365-2567.1998.00401.x","article-title":"Distinct T-cell subtypes induced with whole cell and acellular pertussis vaccines in children","volume":"93","author":"Ryan","year":"1998","journal-title":"Immunology"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X04003822?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X04003822?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,4,28]],"date-time":"2023-04-28T20:46:14Z","timestamp":1682714774000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X04003822"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,10]]},"references-count":64,"journal-issue":{"issue":"31-32","published-print":{"date-parts":[[2004,10]]}},"alternative-id":["S0264410X04003822"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2004.04.033","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2004,10]]}}}